Consistently, patients with OSA showed lower Aβ42 and higher p-tau proteins CSF levels compared to controls, and higher CSF tau proteins levels correlated with the reduction of brain glucose metabolism in a cluster of different brain frontal and parietal regions. The gene discussed is MAPT; the disease is obstructive sleep apnea syndrome.